Considering the synergistic therapeutic effect of LTX-315 with PD-1/PD-L1 targeted therapy and the significant role played by PD-L1/PD-1 in tumor immune escape, the involvement of LTX-315 in the regulation of PD-L1 expression was further investigated. The gene discussed is PDCD1; the disease is neoplasm.